ImmusanT, Inc. — Form D
ImmusanT, Inc. of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2014-12-31. The offering totals $12.8M, of which $12.8M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2014-12-31
- Form: D
- Accession: 0001538991-14-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $12.8M
- Amount sold: $12.8M
- Investors: 2
- Date of first sale: 2014-12-19
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-231198
Issuer
- Name: ImmusanT, Inc.
- CIK: 0001538991
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2010
- Address: One Kendall Square, CAMBRIDGE, MA, 02139
- Phone: 617-401-2154
Officers, directors & promoters (10)
| Name | Role | Location |
|---|
| Craig Estwick | Director | CAMBRIDGE, MA |
| Sundar Kodiyalam | Director | CAMBRIDGE, MA |
| Justin Sun | Director | CAMBRIDGE, MA |
| Steven Gillis | Director | South San Francisco, CA |
| Thomas Daniel | Director | San Francisco, CA |
| Leslie Williams | Director | Cambridge, MA |
| Leslie Williams | Executive Officer | Cambridge, MA |
| Ceclia Gonzalo | Director | Cambridge, MA |
| Kevin Ferro | Director | Cambridge, MA |
| Thomas Koestler | Director | Cambridge, MA |
Other filings by this issuer (1)
More